Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Mar;40(3):827-32.
doi: 10.1161/STROKEAHA.108.528034. Epub 2009 Jan 8.

Thrombolytic therapy for patients who wake-up with stroke

Andrew D Barreto  1 , Sheryl Martin-Schild, Hen Hallevi, Miriam M Morales, Anitha T Abraham, Nicole R Gonzales, Kachi Illoh, James C Grotta, Sean I Savitz
Affiliations

Thrombolytic therapy for patients who wake-up with stroke

Andrew D Barreto et al. Stroke. 2009 Mar.

Abstract

Background and purpose: Approximately 25% of ischemic stroke patients awaken with their deficits. The last-seen-normal time is defined as the time the patient went to sleep, which places these patients outside the window for thrombolysis. The purpose of this study was to describe our center's experience with off-label, compassionate thrombolysis for wake-up stroke (WUS) patients.

Methods: A retrospective review of our database identified 3 groups of ischemic stroke patients: (1) WUS treated with thrombolysis; (2) nontreated WUS; and (3) 0- to 3-hour intravenous tissue plasminogen activator-treated patients. Safety and clinical outcome measures were symptomatic intracerebral hemorrhage, excellent outcome (discharge modified Rankin score, 0-1), favorable outcome (modified Rankin score, 0-2), and mortality. Outcome measures were controlled for baseline NIHSS using logistic regression.

Results: Forty-six thrombolysed and 34 nonthrombolysed WUS patients were identified. Sixty-one percent (28/46) of the treated WUS patients underwent intravenous thrombolysis alone whereas 30% (14/46) were given only intra-arterial thrombolysis. Four patients received both intravenous and intra-arterial thrombolysis (9%). Two symptomatic intracerebral hemorrhages occurred in treated WUS (4.3%). Controlling for NIHSS imbalance, treated WUS had higher rates of excellent (14% vs 6%; P=0.06) and favorable outcome (28% vs 13%; P=0.006), but higher mortality (15% vs 0%) compared to nontreated WUS. A second comparison controlling for baseline NIHSS between treated WUS and 174 intravenous tissue plasminogen activator patients treated within 3 hours of symptoms showed no significant differences in safety and clinical outcomes.

Conclusions: Thrombolysis may be safe in WUS patients. Our center's experience supports considering a prospective, randomized trial to assess the safety and outcome of thrombolysis for this specific patient population.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Time parameters and clinical outcome data.
Figure 2
Figure 2
Timing parameters and clinical outcomes of IV-tPA treated WUS and 0- to 3-hour patients.
See this image and copyright information in PMC

References

    1. The national institute of neurological disorders and stroke rt-pa stroke study group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–1587. - PubMed
    1. Chaturvedi S, Adams HP, Jr, Woolson RF. Circadian variation in ischemic stroke subtypes. Stroke. 1999;30:1792–1795. - PubMed
    1. Fink JN, Kumar S, Horkan C, Linfante I, Selim MH, Caplan LR, Schlaug G. The stroke patient who woke up: Clinical and radiological features, including diffusion and perfusion MRI. Stroke. 2002;33:988–993. - PubMed
    1. Lago A, Geffner D, Tembl J, Landete L, Valero C, Baquero M. Circadian variation in acute ischemic stroke: A hospital-based study. Stroke. 1998;29:1873–1875. - PubMed
    1. Marler JR, Price TR, Clark GL, Muller JE, Robertson T, Mohr JP, Hier DB, Wolf PA, Caplan LR, Foulkes MA. Morning increase in onset of ischemic stroke. Stroke. 1989;20:473–476. - PubMed

Publication types

MeSH terms

Substances